ReviewThe Lancet. Oncology2023

REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment.

Ehsan Ghorani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.